[Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
Zapadniuk
B V
BV
Kravets
A S
AS
Iarosh
A A
AA
Shurinok
L A
LA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D000936:Antigen-Antibody Complex / Q000032:analysis; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology*; D010455:Peptides / Q000627:therapeutic use; D013949:Thymus Extracts / Q000627:therapeutic use; D013951:Thymus Hormones / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000936:Antigen-Antibody Complex; D010455:Peptides; D013949:Thymus Extracts; D013951:Thymus Hormones; C032805:thymalin; C036191:T-activin
Pokazateli kletochnogo i gumoral'nogo immuniteta u bol'nykh rasseiannym sklerozom pri lechenii immunomoduliatorami.